IRB Unanticipated Problem and Adverse Event Policy  

During the conduct of research, various problems may occur. The Principal Investigator (PI) is responsible for reporting these problems for evaluation by the Seattle University IRB, according to federal regulations.

An Adverse Event refers to any untoward or unfavorable medical occurrence in a human subject, including any abnormal sign (e.g., abnormal physical exam or laboratory finding), symptom, or disease, temporally associated with the subject’s participation in the research (whether or not considered related to the subject’s participation in the research). Adverse events encompass physical and psychological harms. They occur primarily in the context of biomedical research, although they may occur with social and behavioral research. Unanticipated Problems encompass “other” events that may arise during the course of research.

Circumstances for reporting Unanticipated Problems

A PI must submit an unanticipated problem report if all three of the following criteria (in accordance with federal regulations) are met:

  1. An incident, experience, or outcome is unexpected (in nature, severity, or frequency), given the procedures described in the IRB-approved research protocol and informed consent document; and given the characteristics of the research subject population.
  2. An incident, experience, or outcome is related to or possibly caused by participation in the research.
  3. An incident, experience, or outcome suggests that the research places subjects or others at a greater risk of harm (including physical, psychological, economic, or social harm) than previously realized or anticipated.

An unanticipated problem may warrant corrective actions in the research protocol or the informed consent process/document in order to ensure the safety, welfare, or rights of participants. Some possible corrective actions may include:

  1. changes to the research protocol initiated by the PI prior to obtaining IRB approval to eliminate immediate hazards to subjects;
  2. modification of inclusion or exclusion criteria to mitigate the newly identified risks;
  3. implementation of additional procedures for monitoring subjects;
  4. suspension of enrollment of new subjects;
  5. suspension of research procedures in currently enrolled subjects;
  6. modification of informed consent documents to include a description of newly recognized risks; and
  7. provision of additional information about newly recognized risks to previously enrolled subjects.

Circumstances for reporting Adverse Events

A PI must submit an unanticipated problem report if all three of the following criteria (in accordance with federal regulations) are met, OR if it is a serious adverse event.

1.       The adverse event is unexpected because the nature, severity, or frequency of the event is not consistent with either:

a)      the known or foreseeable risk of adverse events associated with research procedures described in the IRB-approved research protocol or the current IRB-approved informed consent form.

b)      the expected natural progression of any underlying disease, disorder, or condition of the subject(s) experiencing the adverse event and the subject’s predisposing risk factor profile for the adverse event.

2.       The adverse event is related to or possibly caused by participation in the research. Adverse events may be caused by one or more of the following:

a)      the procedures involved in the research;

b)      an underlying disease, disorder, or condition of the subject; or

c)       other circumstances unrelated to either the research or any underlying disease, disorder, or condition of the subject. 

Adverse events determined to be at least partially caused by a) (above) would be considered related to participation in the research, whereas adverse events determined to be solely caused by (b) or (c) would be considered unrelated to participation in the research. 

3.       The adverse event suggests that the research places subjects or others at a greater risk of harm than previously realized or anticipated. Any serious adverse event requires immediate reporting to the IRB, which has the authority to suspend or terminate approval of research associated with unexpected serious harm to subjects. An adverse event is considered serious if it:

a)      results in death;

b)      is life-threatening (places the subject at immediate risk of death from the event as it occurred);

c)       results in inpatient hospitalization or prolongation of existing hospitalization;

d)      results in a persistent or significant disability/incapacity;

e)      results in a congenital anomaly/birth defect; or

f)       based upon appropriate medical judgment, may jeopardize the subject’s health and may require medical intervention to prevent one of the outcomes listed above.

  

Instructions for reporting an Unanticipated Problem–Adverse Event

w  Review the reporting timeframe below to ensure prompt response.

w  Complete the report form using MS Word or similar word-processing software (no handwritten applications).

w  Respond to all items as applicable, or the report may be returned to you for additional information. Attach additional pages as necessary.

w  Obtain all necessary signatures before submitting your report: PI, Faculty Advisor (if not the PI), and Co-Investigators.

w  Submit all forms in a sealed envelope to:  IRB, Office of Research Services & Sponsored Projects in the University Services Building #203. After business hours, please place materials in mail slot.

 

Required Timeframe for Reporting Unanticipated Problems–Adverse Events

Investigator Must Report the Following

Reporting Timeframe

Identification of an unsafe research environment.

Immediately, when it represents a significant departure from the approved protocol and/or if it affects the welfare or safety of participants.

Threats of harm to participants or others related to their participation in the research.

Immediately by phone.

Change to the protocol made without prior IRB review to eliminate an apparent immediate hazard to participants.

Immediately by phone.

Deaths

Within 24 hours, if subject currently in protocol. Otherwise, within 60 days of investigator’s notification of death.

PThe above instances should be reported to the IRB, key site personnel, and any other authorities overseeing or involved in the research protocol.

Breach of confidentiality.

Within 3 days of discovery.

Any harm experienced by the participant, in the opinion of the investigator, that is both unexpected and more likely than not caused by research procedures.

Within 7 days of occurrence, or within 7 days of a reported occurrence to the PI by participants.

Any other problem that the investigator considers to be unanticipated, and indicates that participants or others are at increased risk of harm.

Within 7 days.

Incarceration of a participant in a protocol not approved to enroll prisoners.

Within 10 days.

Newly discovered information that indicates a change in the risk/benefit ratio.

Within 10 days of discovery.

 

Please direct all questions to:  irb@seattleu.edu  or (206) 296-2585

 

Full Board Review Submission Deadline

 
Deadlines for  upcoming full board IRB meetings. [Some later dates may be subject to change. Please check back regularly for updates.] 

 


Deadline: May 31 (for June 14 full board meeting) 

 

NOTE: The IRB will hold one full-board meeting over the summer.


Deadline: July 25 (for the Aug. 8 full board meeting) 

 

Submissions for EXEMPT & EXPEDITED REVIEWS may occur any time. The above deadline does not apply.

EXEMPT & EXPEDITED REVIEWS take approximately two weeks to complete.

FULL BOARD SUBMISSIONS 
involving prisoner research or research
with minors may require additional review time.

* All deadlines are subject to change. Check here for the latest information.

Questions?

Email: irb@seattleu.edu